Alexion Pharmaceuticals (ALXN) Stock
Alexion Pharmaceuticals (ALXN) has a Tenet Score of 64 of 100 against 374 Healthcare peers, as of Jul 29, 2026.
Key stats
- Market cap
- $40.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Tenet Score
- 64/100
- Solid · 374 Healthcare peers
Industry: Drugs · see every company filed here →
ALEXION PHARMACEUTICALS, INC. scores 64/100. Solid. Strongest on growth and quality versus 374 Healthcare peers.
Tenet Score · vs sector
n=374Factor grades
Momentum omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ~ Piotroski F-Score
- ✓ Munger Compounders
- ✕ Magic Formula
- ~ Quality Compounder
- — Graham Defensive
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a…
Common questions
What sector and industry is Alexion Pharmaceuticals in?
Alexion Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Alexion Pharmaceuticals' Tenet Score?
Alexion Pharmaceuticals' Tenet Score is 64 out of 100, ranked against 374 Healthcare peers as of Jul 29, 2026.

